1. Introduction: An Overview of the anatomy and physiology of the lung 2. An overview, current challenges of drug resistance and targeting metastasis associated with lung cancer 3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer 4. Different drug / drug combination based therapies pertaining to lung cancer 5. Potential of nanotechnology in treatment and overcoming lung cancer resistance 6. Polymeric nanoparticles based drug delivery for lung cancer 7. Metallic nanoparticles based drug delivery for lung cancer 8.

Solid lipid nanoparticles based drug delivery for lung cancer 9. Liposomes and niosomes based drug delivery for lung cancer 10. Dendrimers based drug delivery for lung cancer 11. Micelles based drug delivery for lung cancer 12. Nanoemulsions based drug delivery for lung cancer 13. Hydrogel based drug delivery for lung cancer 14. Quantum dots based drug delivery for lung cancer 15. Nanotechnology-based inhalation treatments for lung cancer 16.

Advances in combination and immunotherapy therapy of lung cancer 17. Nanomedicine under clinical settings: Understanding of the heterogeneity of clinical cancers and several biological factors that influences the properties of nanomedicines in patients 18. Exploitation of clinically relevant animal models for optimization of nanomedicine properties 19. Beyond the lung cancer -- facing new challenges 20. Towards development of novel diagnostic nano-imaging platform for lung cancer 21. Future prospect of nano based drug delivery approaches against lung cancer and expected pitfalls of.